US$ 27.89
glp 1 agonist schizophrenia Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? Impact of Glucagon-like Peptide-1 Receptor
Description
Soon enough, you will find that this personalized process helps rewire your brain when thinking about food and kickstart you to your new, healthy life

For patients using GLP-1 therapy, the goal should not be scale weight alone
This section explores potential future developments, research priorities, and clinical applications of GLP-1-based therapies for adolescent obesity

The SELECT trial demonstrated a 38% CRP reduction regardless of baseline BMI, statin use, or cholesterol levels

Balancing price, safety and efficacy remains key in choosing a GLP-1 medication

The authors use an interesting methodology
